Hemophilia - Bayer Hemophilia Awards Programme 2017/2018

Bayer Healthcare invites applications for its Bayer Hemophilia Awards Programme (BHAP). Deadline to submit a Letter of Intent is November 30, 2017. The programme supports basic and clinical research and education in hemophilia. Through grants provided to early career investigators, fellows in training, and other hemophilia care professionals, the BHAP seeks to support the next steps for the next generation of care and treatment options for people with hemophilia worldwide.

The programme consist of the following for Awards: 

• Special Project Award: The maximum grant is $ 100,000 over one year or $ 200,000 over two years; 
• Early Career Investigator Award: funding of $ 100,000 annually for two years; 
• Fellowship Project Award: funding of up to $ 80,000 annually for two years; 
• Caregiver Award: up to four new awards of up to $ 25,000 will be made annually.